Filing Overview
QT Imaging Holdings, Inc. was not the registrant in this filing. The filing was submitted by GigCapital5, Inc., a Delaware special purpose acquisition company, on January 5, 2022, reporting events occurring on December 31, 2021, and January 5, 2022.
Business Context and Reporting Period
The filing is a Form 8-K under Item 5.02, Item 8.01, and Item 9.01. It reports changes to the board and board committees. GigCapital5’s securities were listed on the New York Stock Exchange under the symbols GIA.U, GIA, and GIA.WS.
Financial Metrics and Liquidity
- The filing does not provide revenue, net income, cash flow, margins, debt, liquidity, or other operating or financial performance metrics.
- No financial statements or financial guidance are included.
Material Changes
- Neil Miotto resigned from the board and its Audit, Compensation, and Nominating and Corporate Governance Committees effective December 31, 2021.
- The filing states that Mr. Miotto’s resignation was not due to any disagreement with the company.
- Sharmila Makhija, MD, MBA, was appointed to the board and each of those three committees effective December 31, 2021.
- Dr. Makhija was also appointed Chair of the Compensation Committee.
- On January 5, 2022, Raanan Horowitz was appointed Chair of the Nominating and Corporate Governance Committee.
- Dr. Makhija will enter into the company’s standard director and officer indemnification agreement. The filing reports no related-party transactions or other arrangements requiring disclosure under Item 404(a) of Regulation S-K.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no operating outlook, financial guidance, contingencies, or specific risk disclosures. The primary reported matters are board and committee composition changes. A press release announcing Dr. Makhija’s appointment was filed as Exhibit 99.1.
Investor Verification Points
- Verify the registrant and transaction context: this filing is by GigCapital5, Inc., not QT Imaging Holdings, Inc.
- Confirm the subsequent business combination or other transaction status in later filings, as this Form 8-K does not provide that information.
- Review Exhibit 99.1 for additional information regarding Dr. Makhija’s appointment.
- Review subsequent filings for updated board composition, committee leadership, and financial information.